$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
施达赛的中文说明书
2025-10-19 11:44:20
Check Details
施达赛贵不贵?多少钱
2025-10-19 11:44:20
Check Details
施达赛国内有吗
2025-10-19 11:44:20
Check Details
施达赛好用吗
2025-10-19 11:44:20
Check Details
施达赛可以治疗哪些疾病
2025-10-19 11:44:20
Check Details
施达赛可用来治疗什么病症
2025-10-19 11:44:20
Check Details
施达赛哪里能买到
2025-10-19 11:44:20
Check Details
施达赛纳入医保了吗
2025-10-19 11:44:20
Check Details
施达赛如何购买
2025-10-19 11:44:20
Check Details
施达赛使用说明
2025-10-19 11:44:20
Check Details
施达赛是一种什么药物呢
2025-10-19 11:44:20
Check Details
施达赛适应症
2025-10-19 11:44:20
Check Details
1
2
...
524
525
526
527
528
529
530
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
3
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
4
A Key Therapeutic Breakthrough Against T315I-Mutant CML
5
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
6
Tafasitamab and Lenalidomide Combination Therapy Guide
7
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
8
Gilteritinib Professional Medication Guide & Dosage Management
9
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
10
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
11
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
12
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation